Abstract
Background Analysis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic sequence data from household infections should aid its detailed epidemiological understanding. Using viral genomic sequence data, we investigated household SARS-CoV-2 transmission and evolution in coastal Kenya households.
Methods We conducted a case-ascertained cohort study between December 2020 and February 2022 whereby 573 members of 158 households were prospectively monitored for SARS-CoV-2 infection. Households were invited to participate if a member tested SARS-CoV-2 positive or was a contact of a confirmed case. Follow-up visits collected a nasopharyngeal/oropharyngeal (NP/OP) swab on days 1, 4 and 7 for RT-PCR diagnosis. If any of these were positive, further swabs were collected on days 10, 14, 21 and 28. Positive samples with an RT-PCR cycle threshold of <33.0 were subjected to whole genome sequencing followed by phylogenetic analysis. Ancestral state reconstruction was used to determine if multiple viruses had entered households.
Results Of 2,091 NP/OP swabs that were collected, 375 (17.9%) tested SARS-CoV-2 positive. Viral genome sequences (>80% coverage) were obtained from 208 (55%) positive samples obtained from 61 study households. These genomes fell within 11 Pango lineages and four variants of concern (Alpha, Beta, Delta and Omicron). We estimated 163 putative transmission events involving members of the sequenced households, 40 (25%) of which were intra-household transmission events while 123 (75%) were infections that likely occurred outside the households. Multiple virus introductions (up-to-5) were observed in 28 (47%) households with the 1-month follow-up period.
Conclusions We show that a considerable proportion of SARS-CoV-2 infections in coastal Kenya occurred outside the household setting. Multiple virus introductions frequently occurred into households within the same infection wave in contrast to observations from high income settings, where single introduction appears to be the norm. Our findings suggests that control of SARS-CoV-2 transmission by household member isolation may be impractical in this setting.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Institute for Health and Care Research (NIHR) (project reference 17/63/82) using UK aid from the UK Government to support global health research, The UK Foreign, Commonwealth and Development Office and Wellcome Trust (grant# 220985). Members of COVID-19 Testing Team at KWTRP are supported by multiple funding sources including UNITAD (BOHEMIA study received by Dr Marta Maia funded UNITAID), EDCTP (Senior Fellowship and Research and Innovation Action (RIA) grants received by Dr Francis Ndungu), GAVI (PCIVS grant received by Prof. Anthony Scott). Dr Simon Dellicour acknowledges support from the Fonds National de la Recherche Scientifique (F.R.S.-FNRS, Belgium; grant nF.4515.22), from the Research Foundation - Flanders (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen, FWO, Belgium; grant nG098321N), and from the European Union Horizon 2020 project MOOD (grant agreement n874850).The views expressed in this publication are those of the author (s) and not necessarily those of NIHR, the Department of Health and Social Care, Foreign Commonwealth and Development Office, Wellcome Trust or the UK government.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was reviewed and approved by both the Scientific and Ethics Research Unit (SERU) at Kenya Medical Research Institute (KEMRI), Nairobi, Kenya (SERU protocol # 4077) and the University of Warwick, Biomedical and Scientific Research Ethics Committee, Coventry, United Kingdom (REF: BSREC 150/19-20 AM01). Prior to data and sample collection, written informed consent was obtained from all participants aged 18 years or older, while for participants aged less than 18 years consent was obtained from their parents or legal guardians. Assent was also sought for adolescents (11-17 years of age).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The consensus genome sequences obtained in this study that passed our quality control filters have been submitted to GISAID database (accession numbers available in appendix pages of the supplementary material). The code for the analyses presented in this manuscript is available from the corresponding author upon request. For more detailed information beyond the metadata used in the paper, there is a process of managed access requiring submission of a request form for consideration by our Data Governance Committee (http://kemri-wellcome.org/about-us/#ChildVerticalTab_15).
